Ghent University Academic Bibliography

Show Sort by

Your filters: cql: issn exact "1078-0432"

Add to list
WRN promoter CpG island hypermethylation does not predict more favorable outcomes for patients with metastatic colorectal cancer treated with irinotecan-based therapy

Linda JW Bosch, Yanxin Luo, Victoria V Lao, Petur Snaebjornsson, Geert Trooskens (UGent) , Ilse Vlassenbroeck, Sandra Mongera, Weiliang Tang, Piri Welcsh, James G Herman, et al.

(2016) CLINICAL CANCER RESEARCH. 22(18). p.4612-4622
Add to list
Targeting MYCN-driven transcription by BET-bromodomain inhibition

Anton G Henssen, Kristina Althoff, Andrea Odersky, Anneleen Beckers (UGent) , Richard Koche, Franki Speleman (UGent) , Simon Schaefer, Emma Bell, Maike Nortmeyer, Frank Westermann, et al.

(2016) CLINICAL CANCER RESEARCH. 22(10). p.2470-2481
Add to list
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers

André Oberthuer, Dilafruz Juraeva, Barbara Hero, Ruth Volland, Carolina Sterz, Rene Schmidt, Andreas Faldum, Yvonne Kahlert, Anne Engesser, Shahab Asgharzadeh, et al.

(2015) CLINICAL CANCER RESEARCH. 21(8). p.1904-1915
Add to list
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Irina Lambertz (UGent) , Candy Kumps (UGent) , Shana Claeys (UGent) , Sven Lindner, Anneleen Beckers (UGent) , Els Janssens, Daniel R Carter, Alex Cazes, Belamy B Cheung, Marilena De Mariano, et al.

(2015) CLINICAL CANCER RESEARCH. 21(14). p.3327-3339
Add to list
A phase I dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma

Markus Hansson, Peter Gimsing, Ashraf Badros, Titti Martinsson Niskanen, Hareth Nahi, Fritz Offner (UGent) , Morten Salomo, Elisabeth Sonesson, Morten Mau-Sorensen, Yvonne Stenberg, et al.

(2015) CLINICAL CANCER RESEARCH. 21(12). p.2730-2736
Add to list
Immune recovery after allogeneic hematopoietic stem cell transplantation following Flu-TBI versus TLI-ATG conditioning

Muriel Hannon, Yves Beguin, Grégory Ehx, Sophie Servais, Laurence Seidel, Carlos Graux, Johan Maertens, Tessa Kerre (UGent) , Coline Daulne, Muriel de Bock, et al.

(2015) CLINICAL CANCER RESEARCH. 21(14). p.3131-3139
Add to list
- Conference Paper
- C3
Delineating the roles of lysine 27 methylation-associated epigenetic modulators in T cell leukemia

Panagiotis Ntziachristos, Grant Welstead, Thomas Trimarchi, Sofia Bakogianni, Luyao Xu, Pieter Van Vlierberghe (UGent) , Rab Prinjha, Adolfo Ferrando, Rudolf Jaenisch, Charles Mullighan, et al.

(2015) CLINICAL CANCER RESEARCH. 21(suppl. 17).
Add to list
- Conference Paper
- C3
Transcriptional antagonism between the cooperative oncogenes TLX1 and NOTCH1 in T-cell acute lymphoblastic leukemia.

Kaat Durinck (UGent) , Wouter Van Loocke (UGent) , Joni Van der Meulen (UGent) , Inge Van de Walle (UGent) , Pieter Rondou (UGent) , Charles E De Bock, Bruce Poppe (UGent) , Jan Cools, Jean Soulier, Tom Taghon (UGent) , et al.

(2015) Clin. Cancer Res.. In CLINICAL CANCER RESEARCH 21(suppl. 17).
Add to list
- Journal Article
- A1
Correlation between prostate-specific antigen kinetics and overall survival in abiraterone acetate-treated castration-resistant prostate cancer patients

Xu S Xu, Charles J Ryan, Kim Stuyckens, Matthew R Smith, Fred Saad, Thomas W Griffin, Youn C Park, Margaret K Yu, An Vermeulen (UGent) , Italo Poggesi, et al.

(2015) CLINICAL CANCER RESEARCH. 21(14). p.3170-3177
Add to list
- Conference Paper
- C3
Population pharmacokinetic-pharmacodynamic (PKPD) modeling of ibrutinib in patients with B-cell malignancies

Italo Poggesi, Maria Luisa Sardu, Eleonora Marostica (UGent) , Juthamas Sukbuntherng, Betty Y Chang, Jan de Jong, Xavier Woot de Trixhe, An Vermeulen (UGent) , Giuseppe De Nicolao, Susan Mary O'Brien, et al.

(2015) CLINICAL CANCER RESEARCH. 21(suppl. 17).

← Previous

Academic Bibliography

WRN promoter CpG island hypermethylation does not predict more favorable outcomes for patients with metastatic colorectal cancer treated with irinotecan-based therapy

Targeting MYCN-driven transcription by BET-bromodomain inhibition

Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers

Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

A phase I dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma

Immune recovery after allogeneic hematopoietic stem cell transplantation following Flu-TBI versus TLI-ATG conditioning

Delineating the roles of lysine 27 methylation-associated epigenetic modulators in T cell leukemia

Transcriptional antagonism between the cooperative oncogenes TLX1 and NOTCH1 in T-cell acute lymphoblastic leukemia.

Correlation between prostate-specific antigen kinetics and overall survival in abiraterone acetate-treated castration-resistant prostate cancer patients

Population pharmacokinetic-pharmacodynamic (PKPD) modeling of ibrutinib in patients with B-cell malignancies

Contents

Support

Contact